(Q43907208)

English

Results of 2 years of treatment with protease-inhibitor--containing antiretroviral therapy in dutch children infected with human immunodeficiency virus type 1.

scientific article published on 4 March 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880968%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Results of 2 years of treatment with protease-inhibitor--containing antiretroviral therapy in dutch children infected with human immunodeficiency virus type 1 (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880968%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880968%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Annemarie van Rossum

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880968%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Martin Schutten

9

object named as

Martin Schutten

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880968%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

author name string

Sibyl P M Geelen

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880968%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Nico G Hartwig

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880968%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Tom F W Wolfs

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880968%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Corry M R Weemaes

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880968%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Henriëtte J Scherpbier

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880968%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Ellen G van Lochem

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880968%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Wim C J Hop

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880968%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

David M Burger

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880968%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Ronald de Groot

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880968%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

language of work or name

0 references

publication date

4 March 2002

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880968%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Clinical Infectious Diseases

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880968%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

34

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880968%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1008-1016

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880968%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880968%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. Pediatric AIDS Clinical Trials Group 382 Team

1 reference

https://api.crossref.org/works/10.1086%2F339443

21 January 2018

Clinical and virologic response to combination treatment with indinavir, zidovudine, and lamivudine in children with human immunodeficiency virus-1 infection: a multicenter study in the Netherlands. On behalf of the Dutch Study Group for Children wi

1 reference

https://api.crossref.org/works/10.1086%2F339443

21 January 2018

Combination therapy with saquinavir soft gelatin capsules in children with human immunodeficiency virus infection.

1 reference

https://api.crossref.org/works/10.1086%2F339443

21 January 2018

Clinical and immuno-virologic characterization of the efficacy of stavudine, lamivudine, and indinavir in human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1086%2F339443

21 January 2018

Body mass index reference curves for the UK, 1990

1 reference

https://api.crossref.org/works/10.1086%2F339443

21 January 2018

Pharmacokinetics of the protease inhibitor indinavir in human immunodeficiency virus type 1-infected children.

1 reference

https://api.crossref.org/works/10.1086%2F339443

21 January 2018

Growth failure as a prognostic indicator of mortality in pediatric HIV infection

1 reference

https://api.crossref.org/works/10.1086%2F339443

21 January 2018

Growth as a prognostic indicator in children with human immunodeficiency virus infection treated with zidovudine. AIDS Clinical Trials Group Protocol 043 Study Group

1 reference

https://api.crossref.org/works/10.1086%2F339443

21 January 2018

Immunological and virological responses in HIV-1-infected adults at early stage of established infection treated with highly active antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1086%2F339443

21 January 2018

3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine

1 reference

https://api.crossref.org/works/10.1086%2F339443

21 January 2018

Suppression of plasma virus load below the detection limit of a human immunodeficiency virus kit is associated with longer virologic response than suppression below the limit of quantitation

1 reference

https://api.crossref.org/works/10.1086%2F339443

21 January 2018

A one year experience: T cell responses and viral replication in children with advanced human immunodeficiency virus type 1 disease treated with combination therapy including ritonavir

1 reference

https://api.crossref.org/works/10.1086%2F339443

21 January 2018

Immunologic and virologic responses to HAART in severely immunocompromised HIV-1-infected children.

1 reference

https://api.crossref.org/works/10.1086%2F339443

21 January 2018

A phase I/II study of the protease inhibitor ritonavir in children with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1086%2F339443

21 January 2018

Protease inhibitor therapy in children with perinatally acquired HIV infection

1 reference

https://api.crossref.org/works/10.1086%2F339443

21 January 2018

Clinical, virologic and immunologic responses of children with advanced human immunodeficiency virus type 1 disease treated with protease inhibitors

1 reference

https://api.crossref.org/works/10.1086%2F339443

21 January 2018

Combination treatment with zidovudine, didanosine, and nevirapine in infants with human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1086%2F339443

21 January 2018

Comparison of two antiretroviral triple combinations including the protease inhibitor indinavir in children infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1086%2F339443

21 January 2018

A pilot study of combination therapy with indinavir, stavudine (d4T), and didanosine (ddI) in children infected with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1086%2F339443

21 January 2018

Indinavir pharmacokinetics and parmacodynamics in children with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1086%2F339443

21 January 2018

Pharmacologic characteristics of indinavir, didanosine, and stavudine in human immunodeficiency virus-infected children receiving combination therapy

1 reference

https://api.crossref.org/works/10.1086%2F339443

21 January 2018

Treatment of human immunodeficiency virus 1-infected infants and children with the protease inhibitor nelfinavir mesylate

1 reference

https://api.crossref.org/works/10.1086%2F339443

21 January 2018

A phase I/II study of the protease inhibitor indinavir in children with HIV infection

1 reference

https://api.crossref.org/works/10.1086%2F339443

21 January 2018

Viral measurement by polymerase chain reaction-based assays in human immunodeficiency virus-infected infants

1 reference

https://api.crossref.org/works/10.1086%2F339443

21 January 2018

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1086%2F339443

21 January 2018

Urological complaints in relation to indinavir plasma concentrations in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1086%2F339443

21 January 2018

Combination Nucleoside Analog Reverse Transcriptase Inhibitor(s) Plus Nevirapine, Nelfinavir, or Ritonavir in Stable Antiretroviral Therapy-Experienced HIV-Infected Children: Week 24 Results of a Randomized Controlled Trial - PACTG 377

1 reference

https://api.crossref.org/works/10.1086%2F339443

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43907208&oldid=2104313073"